Pharmacovigilance

Pharmacovigilance and Drug Safety services for patient safety

Our expert teams ensure safety from clinical development to post-marketing, combining global expertise with local insight. We deliver end-to end vigilance solutions to support compliance and patient protection.

Aixial’s achievements & specialties

Protecting patient safety, ensuring regulatory excellence


At Aixial Group, we deliver end-to-end pharmacovigilance solutions designed to ensure patient safety, regulatory compliance, and operational excellence. Our integrated approach combines expert-driven services, advanced technologies, and proven methodologies to support pharmaceutical and biotech companies across the entire safety lifecycle.

What we deliver

  • We support the full pharmacovigilance lifecycle with high-quality, compliant deliverables:
  • Literature surveillance & signal identification
  • End-to-end case management (ICSRs)
  • Periodic safety reports (PSUR, DSUR, PBRER)
  • Risk Management Plans (RMP)
  • Signal detection & monitoring
  • SDEA management
  • Medical information handling
  • Inspection & audit support

Expert team in Pharmacovigilance

With an average of 24 years of experience for each team member, we have successfully provided services to over 160 studies across the US and Europe. We have strong local and global coverage with involvement in product approvals, including processes from early phase to NDA, and expertly managing EU CT safety submissions with a focus on regulatory compliance.

How can we support your next project?

Whether you’re looking for a protocol review or a proposal,

simply reach out to us by filling our request for proposal.

Insights